Reflecting the absence of a clear treatment effect, RA patients with very low frequencies of TNF‐α+IFN‐γ+CD107a+ CD27−CD28− CD4+ T cells (<1%) showed wide treatment heterogeneity and included untreated newly diagnosed individuals (Figure S5). This evidence concerns the gene IFNG and rheumatoid arthritis.